Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.hcgoncology.com | |
Market Cap | 5,130.74 Cr. | |
Enterprise Value(EV) | 5,449.92 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.53 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 145.55 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.57 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 61.83 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 5.96 | Calculated using Price: 368.35 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 13.93 Cr. | 139,289,687 Shares |
FaceValue | 10 | |
About Healthcare Global Enterprises Ltd. | ||
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand. |
1 Day |
|
-0.81% |
1 Week |
|
-2.65% |
1 Month |
|
+7.22% |
3 Month |
|
+1.62% |
6 Month |
|
-0.94% |
1 Year |
|
+37.18% |
2 Year |
|
+25.35% |
5 Year |
|
+82.03% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 1.75 | 0.64 | 5.38 | 3.71 | -6.48 | -29.68 | -43.32 | 5.16 | 2.06 | |
Return on Capital Employed (%) | 6.41 | 5.6 | 7.22 | 7.59 | 3.46 | 1.65 | -9.66 | 15.17 | 11.69 | |
Return on Assets (%) | 0.64 | 0.25 | 2.06 | 1.29 | -2.03 | -6.51 | -10.46 | 1.85 | 0.78 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 279 | 426 | 433 | 515 | 477 | 381 | 697 | 870 | 861 | 858 | |
Non Curr. Liab. | 279 | 306 | 354 | 483 | 557 | 1,232 | 822 | 860 | 871 | 916 | |
Curr. Liab. | 187 | 263 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | 637 | |
Minority Int. | 25 | 33 | 57 | 64 | 46 | 39 | 17 | 13 | 9 | 3 | |
Equity & Liab. | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,311 | 2,413 | |
Non Curr. Assets | 648 | 800 | 966 | 1,200 | 1,354 | 1,923 | 1,566 | 1,711 | 1,730 | 1,820 | |
Curr. Assets | 122 | 227 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | 594 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,311 | 2,413 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,691 | 1,859 | |
Other Income | 5 | 4 | 10 | 19 | 10 | 10 | 21 | 16 | 32 | 17 | |
Total Income | 524 | 588 | 710 | 848 | 986 | 1,103 | 1,030 | 1,410 | 1,723 | 1,876 | |
Total Expenditure | -443 | -499 | -595 | -716 | -853 | -923 | -887 | -1,160 | -1,411 | -1,545 | |
PBIDT | 81 | 89 | 115 | 132 | 133 | 179 | 144 | 251 | 312 | 330 | |
Interest | -34 | -38 | -23 | -42 | -70 | -138 | -119 | -98 | -104 | -108 | |
Depreciation | -39 | -44 | -57 | -71 | -85 | -148 | -159 | -158 | -163 | -171 | |
Taxation | 2 | 2 | -12 | -10 | 3 | -6 | 8 | -49 | -27 | -29 | |
Exceptional Items | -5 | -6 | 11 | -93 | 95 | ||||||
PAT | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | 23 | |
Minority Interest | -4 | -4 | -1 | 4 | 6 | 19 | 28 | 15 | 12 | 12 | |
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 1 | -1 | 22 | 21 | -25 | -107 | -193 | 54 | 29 | 35 | |
Adjusted EPS | 0 | 0 | 3 | 2 | -3 | -12 | -15 | 4 | 2 | 3 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 50 | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | 252 | |
Cash Fr. Inv. | -58 | -80 | -204 | -210 | -282 | -238 | -101 | -171 | 125 | -133 | |
Cash Fr. Finan. | 23 | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | |
Net Change | 15 | 2 | 85 | -29 | -23 | -56 | -30 | 62 | 190 | -22 | |
Cash & Cash Eqvt | 25 | 25 | 80 | 51 | 27 | -29 | -59 | 3 | 193 | 171 |
Tue, 16 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Tue, 16 Apr 2024
Compliance Under Reg 40 (9) Of SEBI LODR Regulaitons 2015 Compliance under Regulations 40 (9) of SEBI (LODR) Regulations 2015 |
Tue, 16 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate that the securities dematerialized/rematerialized during the quarter ended March 31 2024 have been furnished to Stock Exxchanges |
Fri, 19 Apr 2024 |
Close Within 52 Week High Zone |
High Increase in 1 Month |
High Increase in 1 Year |
20 SMA Crossing 200 SMA From Below |
MFI Trending Up |